Evoke Pharma Inc (EVOK)

Jun 18, 2025

Evoke Pharma (NASDAQ:EVOK) Stock Price Crosses Below Two Hundred Day Moving Average – What’s Next? - Defense World

Jun 18, 2025

Jun 18, 2025

Spine Injury Solutions (OTCMKTS:SPIN) Stock Price Crosses Below 200-Day Moving Average – Should You Sell? - Defense World

Jun 18, 2025

Jun 14, 2025

Breakeven On The Horizon For Evoke Pharma, Inc. (NASDAQ:EVOK) - Yahoo Finance

Jun 14, 2025

Jun 11, 2025

Gastroparesis Treatment Market Booming Worldwide with - openPR.com

Jun 11, 2025

Jun 05, 2025

Diabetic Gastroparesis Pipeline 2025: Key Developments, - openPR.com

Jun 05, 2025

May 27, 2025

Geriatric Medicines Market Expands Globally with Aging - openPR.com

May 27, 2025

May 26, 2025

Diabetic Gastroparesis Treatment Market Size, Trends & - openPR.com

May 26, 2025

May 23, 2025

Global Geriatric Medicines Market Generated Opportunities, - openPR.com

May 23, 2025

May 22, 2025

Diabetic Gastroparesis Treatment Market in 2025-2032 Detailed - openPR.com

May 22, 2025

May 15, 2025

Evoke Pharma (NASDAQ:EVOK) Earns Sell Rating from Analysts at StockNews.com - Defense World

May 15, 2025

May 15, 2025

Barclays PLC Makes New $122,000 Investment in Innovator Equity Defined Protection ETF – 2 Yr to July 2026 (BATS:AJUL) - Defense World

May 15, 2025

May 15, 2025

Raymond James Financial Inc. Takes Position in Metalla Royalty & Streaming Ltd. (NYSEMKT:MTA) - Defense World

May 15, 2025

May 15, 2025

Evoke Pharma Reports Strong Q1 2025 Sales Growth - TipRanks

May 15, 2025

May 14, 2025

Evoke Pharma Reports First Quarter 2025 Financial Results and Pr - GuruFocus

May 14, 2025

May 13, 2025

Evoke Pharma, Inc. Q1 Loss Decreases, But Misses Estimates - Nasdaq

May 13, 2025

May 13, 2025

Evoke Pharma Inc reports results for the quarter ended March 31Earnings Summary - TradingView

May 13, 2025

May 13, 2025

Evoke Pharma Q1 Operating Expenses USD 4.4 Million - marketscreener.com

May 13, 2025

May 13, 2025

Evoke Pharma Reports First Quarter 2025 Financial Results and Provides Business Update - The Manila Times

May 13, 2025

May 13, 2025

Evoke Pharma Reports 77% Increase in Q1 2025 Net Product Sales, Driven by GIMOTI Adoption and Provider Engagement - Nasdaq

May 13, 2025

May 11, 2025

Evoke Pharma (EVOK) to Release Earnings on Tuesday - Defense World

May 11, 2025

May 07, 2025

Evoke Pharma (NASDAQ:EVOK) Now Covered by Analysts at StockNews.com - Defense World

May 07, 2025

Apr 29, 2025

StockNews.com Initiates Coverage on Evoke Pharma (NASDAQ:EVOK) - Defense World

Apr 29, 2025

Apr 28, 2025

Evoke Pharma (EVOK) to Present Key Metoclopramide Study at DDW 2025 | EVOK Stock News - GuruFocus

Apr 28, 2025

Apr 28, 2025

Evoke Pharma to Present New Data Comparing Tardive Dyskinesia In - GuruFocus

Apr 28, 2025

Apr 28, 2025

Evoke Pharma Announces Presentation of New Research on Tardive Dyskinesia at Digestive Disease Week 2025 - Nasdaq

Apr 28, 2025

Apr 28, 2025

Hudbay Signs Exploration Agreement with the Mosakahiken Cree Nation for the Talbot Deposit in Manitoba - The Manila Times

Apr 28, 2025

Apr 28, 2025

Evoke Pharma to Present New Data Comparing Tardive - GlobeNewswire

Apr 28, 2025

Apr 28, 2025

Groundbreaking Safety Analysis: How 100M+ Patient Study Could Reshape Metoclopramide Treatment Guidelines - Stock Titan

Apr 28, 2025

Apr 27, 2025

Press Release Distribution & PR Platform - ACCESS Newswire

Apr 27, 2025

Apr 25, 2025

Functional Dyspepsia Drug Industry Report 2025-2034: Market Dynamics, Trends, and Forecasts - WhaTech

Apr 25, 2025

Apr 19, 2025

Evoke Pharma, Inc. (NASDAQ:EVOK) Short Interest Update - Defense World

Apr 19, 2025

Apr 19, 2025

FY2025 Earnings Estimate for TSE:MNO Issued By Cormark - Defense World

Apr 19, 2025

Apr 17, 2025

Vincerx Pharma, Inc. Announces Intent to Delist from Nasdaq and Deregister with the SEC - Yahoo Finance

Apr 17, 2025

Apr 15, 2025

Top Market Trend Impacting Digestive and Intestinal Remedies Development in the Coming Years:Technological ... - WhaTech

Apr 15, 2025

Apr 09, 2025

Evoke Pharma stock hits 52-week low at $2.01 amid downturn By Investing.com - Investing.com South Africa

Apr 09, 2025

Apr 09, 2025

Evoke Pharma stock hits 52-week low at $2.01 amid downturn - Investing.com India

Apr 09, 2025

Apr 07, 2025

Evoke Pharma, Inc. (NASDAQ:EVOK) Q4 2024 Earnings Call Transcript - MSN

Apr 07, 2025

Apr 05, 2025

StockNews.com Begins Coverage on Evoke Pharma (NASDAQ:EVOK) - Defense World

Apr 05, 2025

Apr 04, 2025

US Reciprocal Tariffs Evoke Mixed Response From India Inc - Free Press Journal

Apr 04, 2025

Apr 04, 2025

Is The Market Punishing Lynch Group Holdings Limited (ASX:LGL) For Its Mixed Fundamentals? - AInvest

Apr 04, 2025

Apr 03, 2025

Gastroparesis Market Growth to Accelerate in Forecast Period - openPR.com

Apr 03, 2025

Apr 02, 2025

Evoke Pharma stock hits 52-week low at $2.43 amid challenges By Investing.com - Investing.com South Africa

Apr 02, 2025

Apr 02, 2025

Evoke Pharma stock hits 52-week low at $2.43 amid challenges - Investing.com India

Apr 02, 2025

Apr 01, 2025

Short Interest in Evoke Pharma, Inc. (NASDAQ:EVOK) Declines By 32.7% - Defense World

Apr 01, 2025

Apr 01, 2025

Tenaz Energy Corp. (OTCMKTS:ATUUF) Short Interest Update - Defense World

Apr 01, 2025